BLOPEPBOLANG BIOTECHNOLOGY

Tuftsin-related research peptide

Selank

Selank is studied in neuropeptide and behavioral research. The linked experimental work examines inhibition of enkephalin-degrading enzymes.

BLOPEP vial — representative image
Representative image
Quantity per vial

Select variantCompare prices and choose a variant to set the quantity and add it to your quote.

Subtotal excludes freight and taxes. Availability and final terms are confirmed in the quote. Commercial and shipping terms

Mechanism and findings →

Mechanism and findings

In vitro · Study formulation · Plasma enzyme assays

Enkephalin degradation

Selank inhibited enzymatic enkephalin hydrolysis in plasma assays; this is mechanistic evidence, not proof of clinical efficacy.

Zozulya et al., 2001 →

Literature findings; refer to the model and formulation studied.

Mechanism of action

Selank — tuftsin-related research peptide. The literature identity must be matched to the documented chemical form and composition of the supplied material.

The work examined enzymatic enkephalin hydrolysis in plasma and its inhibition by Selank. This is a mechanistic hypothesis related to preserving endogenous peptides and must be distinguished from a clinical trial demonstrating symptom improvement.

  • Enkephalin-degrading enzymes

Zozulya et al., 2001

Studied findings 1
In vitro · Study formulation

Enkephalin degradation

Plasma enzyme assays

Selank inhibited enzymatic enkephalin hydrolysis in plasma assays; this is mechanistic evidence, not proof of clinical efficacy.

View context
Study design
Original-study abstract; experimental design described in linked source
Sample scope / arm
Not extracted; consult original study
Comparator
See original-study context
Experimental context (not instructions for use)
Abstract-level extraction; full methods and tables still require review.
Source section / table / abstract
Abstract

Evidence concerns the studied material and model, not the supplied BLOPEP batch.

Zozulya et al., 2001

Sources and studies 2Peptide Monographs
  1. Selank — PubChem molecular identity

  2. The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity.

    Zozulya AA, Kost NV, Yu Sokolov O, Gabaeva MV, Grivennikov IA, Andreeva LN, Zolotarev YA, Ivanov SV, Andryushchenko AV, Myasoedov NF, Smulevich AB · 2001 · Bulletin of experimental biology and medicine

    DOI: 10.1023/a:1017979514274

Specifications and packaging

Nominal variant content; analytical results belong to the documented batch.

Material type
Peptide
Molecular formula (literature identity)
C33H57N11O9
Molecular weight (literature identity)
751.9 g/mol

Quality and analyses

Review specifications, analytical results and documentation for published batches.

Purity
>99%
Type
Declared specification

Published batches

Batch results have not yet been published on this page.

Look up batch

Storage

Consult the specific conditions in the supplied material documentation.

Delivery and commercial terms

Freight, timing and import terms will be confirmed in the quote for the selected destination.

Other materials in this area

View category →